SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2
Abstract Dysregulation of PI3K/Akt signaling is a dominant feature in basal-like or triple-negative breast cancers (TNBC). However, the mechanisms regulating this pathway are largely unknown in this subset of aggressive tumors. Here we demonstrate that the transcription factor SOX4 is a key regulato...
Guardado en:
Autores principales: | Gaurav A. Mehta, Steven P. Angus, Christen A. Khella, Kevin Tong, Pooja Khanna, Shelley A. H. Dixon, Michael P. Verzi, Gary L. Johnson, Michael L. Gatza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b80593287fd5486295801c1046cbf0bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Katharina Leitner, et al.
Publicado: (2020) -
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
por: Hae In Choi, et al.
Publicado: (2021) -
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
por: Lei Gao, et al.
Publicado: (2019) -
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
por: Yibo Xue, et al.
Publicado: (2019) -
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
por: Afzal Husain, et al.
Publicado: (2016)